Motley Fool Wealth Management LLC cut its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 14.4% in the 4th quarter, Holdings Channel reports. The fund owned 17,515 shares of the biotechnology company’s stock after selling 2,936 shares during the period. Motley Fool Wealth Management LLC’s holdings in Axon Enterprise were worth $9,947,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. New Millennium Group LLC acquired a new stake in shares of Axon Enterprise during the third quarter valued at about $29,000. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the second quarter valued at about $37,000. Creative Financial Designs Inc. ADV acquired a new stake in shares of Axon Enterprise during the fourth quarter valued at about $28,000. Sound Income Strategies LLC grew its stake in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after acquiring an additional 44 shares in the last quarter. Finally, Camelot Portfolios LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter valued at about $30,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Axon Enterprise News Summary
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Axon continues to receive favorable analyst coverage, with a “Moderate Buy” consensus and an average price target of $712.75, suggesting Wall Street still sees meaningful upside from current levels.
- Positive Sentiment: The stock has also been supported by strong recent fundamentals, including the company’s latest earnings beat and revenue growth, which helped drive a strong run earlier in the month. Article Title
- Neutral Sentiment: AXON Networks announced the acquisition of Greenwave Systems, a deal that expands its OSS/BSS and wireless orchestration capabilities. This is a strategic growth update, but it appears unrelated to Axon Enterprise’s core public-safety business. Article Title
- Neutral Sentiment: Short-interest data showed no meaningful change in the near term, so it does not appear to be a major driver of the stock’s move.
- Negative Sentiment: Several insiders, including the CEO, president, and CRO, sold shares under pre-arranged trading plans. While these sales may be routine, they can still weigh on investor sentiment when the stock is already trading lower. Article Title
- Negative Sentiment: The stock’s recent pullback also reflects broader profit-taking after a strong monthly run, especially as Axon remains richly valued versus earnings.
Analyst Upgrades and Downgrades
Check Out Our Latest Analysis on AXON
Axon Enterprise Stock Performance
Shares of AXON stock opened at $452.51 on Wednesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $885.91. The company’s 50-day simple moving average is $408.90 and its 200-day simple moving average is $490.57. The stock has a market capitalization of $36.47 billion, a price-to-earnings ratio of 181.73, a PEG ratio of 8.56 and a beta of 1.45.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm had revenue of $807.35 million for the quarter, compared to analysts’ expectations of $778.91 million. During the same quarter last year, the company posted $1.47 earnings per share. Axon Enterprise’s revenue was up 33.7% on a year-over-year basis. Equities analysts anticipate that Axon Enterprise, Inc will post 1.82 earnings per share for the current fiscal year.
Insider Transactions at Axon Enterprise
In other Axon Enterprise news, CRO Cameron Brooks sold 1,242 shares of the firm’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $621,000.00. Following the transaction, the executive owned 49,710 shares of the company’s stock, valued at $24,855,000. This trade represents a 2.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the firm’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $485.00, for a total transaction of $753,690.00. Following the completion of the transaction, the insider directly owned 34,024 shares in the company, valued at $16,501,640. This represents a 4.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 39,344 shares of company stock valued at $19,267,315 over the last ninety days. Insiders own 4.20% of the company’s stock.
About Axon Enterprise
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Articles
- Five stocks we like better than Axon Enterprise
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
